Acorah Software Products - Accounts Production 16.7.461 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 11900750 Mr Khurshid Hussain Mr Khalid Iqbal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11900750 2024-03-31 11900750 2025-03-31 11900750 2024-04-01 2025-03-31 11900750 frs-core:Non-currentFinancialInstruments 2025-03-31 11900750 frs-core:ShareCapital 2025-03-31 11900750 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 11900750 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11900750 frs-bus:AbridgedAccounts 2024-04-01 2025-03-31 11900750 frs-bus:SmallEntities 2024-04-01 2025-03-31 11900750 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11900750 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11900750 frs-core:CostValuation 2024-03-31 11900750 frs-core:CostValuation 2025-03-31 11900750 frs-bus:Director1 2024-04-01 2025-03-31 11900750 frs-bus:Director2 2024-04-01 2025-03-31 11900750 frs-countries:EnglandWales 2024-04-01 2025-03-31 11900750 2023-03-31 11900750 2024-03-31 11900750 2023-04-01 2024-03-31 11900750 frs-core:Non-currentFinancialInstruments 2024-03-31 11900750 frs-core:ShareCapital 2024-03-31 11900750 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Superpharm Holdings Ltd
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 March 2025
Howe Bridge Consulting
Bartle House
Oxford Court
Manchester
M2 3WQ
Superpharm Holdings Ltd
Contents
Contents

| Page
--- | ---
Abridged Balance Sheet | 1
Notes to the Abridged Financial Statements | 2

Page 1
Superpharm Holdings Ltd
Abridged Balance Sheet
As At 31 March 2025
Abridged Balance Sheet
Registered number: 11900750

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Investments | 4 |  | 1,988,900 |  | 1,988,900
|  |  | 1,988,900 |  | 1,988,900
CURRENT ASSETS
Cash at bank and in hand |  | 157 |  | 157 |
|  | 157 |  | 157 |
NET CURRENT ASSETS (LIABILITIES) |  |  | 157 |  | 157
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 1,989,057 |  | 1,989,057
Creditors: Amounts Falling Due After More Than One Year |  |  | (990,200 ) |  | (990,200 )
NET ASSETS |  |  | 998,857 |  | 998,857
CAPITAL AND RESERVES
Called up share capital | 5 |  | 1,000,000 |  | 1,000,000
Profit and Loss Account |  |  | (1,143 ) |  | (1,143 )
SHAREHOLDERS' FUNDS |  |  | 998,857 |  | 998,857

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 March 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board

Mr Khalid Iqbal Director
05/12/2025

The notes on page 2 form part of these financial statements.
Page 1
Page 2
Superpharm Holdings Ltd
Notes to the Abridged Financial Statements
For The Year Ended 31 March 2025
Notes to the Abridged Financial Statements
1. General Information
Superpharm Holdings Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11900750 . The registered office is Benchill Pharmacy, 206 Holly Hedge Road, Manchester, M22 4QN.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 1)
2 1
4. Investments

| Total
--- | ---
| £
Cost or Valuation
As at 1 April 2024 | 1,988,900
As at 31 March 2025 | 1,988,900
Provision
As at 1 April 2024 | -
As at 31 March 2025 | -
Net Book Value
As at 31 March 2025 | 1,988,900
As at 1 April 2024 | 1,988,900

5. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1,000,000 |  | 1,000,000

Page 2